469 related articles for article (PubMed ID: 35880388)
21. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota dysbiosis characterized by abnormal elevation of
Liang X; Li Y; Cheng L; Wu Y; Wu T; Wen J; Huang D; Liao Z; Tan C; Luo Y; Liu Y
Front Cell Infect Microbiol; 2023; 13():1243512. PubMed ID: 37692165
[TBL] [Abstract][Full Text] [Related]
23. Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals.
Palmu J; Salosensaari A; Havulinna AS; Cheng S; Inouye M; Jain M; Salido RA; Sanders K; Brennan C; Humphrey GC; Sanders JG; Vartiainen E; Laatikainen T; Jousilahti P; Salomaa V; Knight R; Lahti L; Niiranen TJ
J Am Heart Assoc; 2020 Aug; 9(15):e016641. PubMed ID: 32691653
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
25. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
26. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea.
Badran M; Mashaqi S; Gozal D
Expert Opin Ther Targets; 2020 Dec; 24(12):1263-1282. PubMed ID: 33180654
[No Abstract] [Full Text] [Related]
27. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.
Mahmud MR; Akter S; Tamanna SK; Mazumder L; Esti IZ; Banerjee S; Akter S; Hasan MR; Acharjee M; Hossain MS; Pirttilä AM
Gut Microbes; 2022; 14(1):2096995. PubMed ID: 35866234
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
Zhou Z; Sun B; Yu D; Zhu C
Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
[TBL] [Abstract][Full Text] [Related]
29. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis.
Sherman SB; Sarsour N; Salehi M; Schroering A; Mell B; Joe B; Hill JW
Gut Microbes; 2018; 9(5):400-421. PubMed ID: 29469650
[TBL] [Abstract][Full Text] [Related]
30. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
31. Obstructive Sleep Apnea and Systemic Hypertension: Gut Dysbiosis as the Mediator?
Mashaqi S; Gozal D
J Clin Sleep Med; 2019 Oct; 15(10):1517-1527. PubMed ID: 31596218
[TBL] [Abstract][Full Text] [Related]
32. Microbiome and hypertension: where are we now?
Vallianou NG; Geladari E; Kounatidis D
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
34. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
[TBL] [Abstract][Full Text] [Related]
35. Probiotics
Zhang Y; Zheng T; Ma D; Shi P; Zhang H; Li J; Sun Z
mSystems; 2023 Dec; 8(6):e0033123. PubMed ID: 37855616
[TBL] [Abstract][Full Text] [Related]
36. Hypertension promotes microbial translocation and dysbiotic shifts in the fecal microbiome of nonhuman primates.
Vemuri R; Ruggiero A; Whitfield JM; Dugan GO; Cline JM; Block MR; Guo H; Kavanagh K
Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H474-H485. PubMed ID: 35148233
[TBL] [Abstract][Full Text] [Related]
37. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
38. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
40. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
